SlideShare is now on Android. 15 million presentations at your fingertips.  Get the app

×
  • Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
 

Global pharmaceutical & biotechnology outlook 2013 mature biotech - Reports Corner

by Working at Reports Corner on Apr 27, 2013

  • 353 views

Profitable Biotech (Mature Biotech) and non-Profitable Biotech companies (Rising stars) have developed innovative drugs for treatment of chronic and non chronic diseases. In the next five years the ...

Profitable Biotech (Mature Biotech) and non-Profitable Biotech companies (Rising stars) have developed innovative drugs for treatment of chronic and non chronic diseases. In the next five years the distinction between mature biotech companies and large global pharma is likely to disappear as investment in R&D and acquisition start delivering and Market Cap match the large global pharma.

https://www.reportscorner.com/reports/10017/Global-Pharmaceutical-&-Biotechnology-Outlook-2013:-Mature-Biotech/

Statistics

Views

Total Views
353
Views on SlideShare
353
Embed Views
0

Actions

Likes
0
Downloads
6
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via SlideShare as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
Post Comment
Edit your comment

Global pharmaceutical & biotechnology outlook 2013 mature biotech - Reports Corner Global pharmaceutical & biotechnology outlook 2013 mature biotech - Reports Corner Presentation Transcript